Trial Profile
A phase 2 study of the toxin binding polymer tolevamer in patients with C. difficile associated diarrhoea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2018
Price :
$35
*
At a glance
- Drugs Tolevamer (Primary) ; Vancomycin
- Indications Clostridium difficile infections; Diarrhoea
- Focus Therapeutic Use
- 06 Feb 2018 New trial record.